Patients with chronic kidney disease experience metabolic bone disease, commonly osteitis fibrosa cystica or osteomalacia. While surgery treats osteitis fibrosa cystica, desferrioxamine shows promise for treating osteomalacia.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: